Balmonds Overview
- Founded
-
2007

- Status
-
Public
- Employees
-
10

- Investments
-
1
Balmonds General Information
Description
Developer of skincare products intended to offer products for sensitive skin. The company's products are suitable for dry skin, eczema, psoriasis, dermatitis, and allergy-prone skin and also are a non-steroidal moisturizer that is both prescribed and alternative, enabling users to avail the products at a reasonable rate.
Contact Information
Website
www.balmonds.co.uk
Formerly Known As
Purepotions
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Personal Products
Other Industries
Internet Retail
Primary Office
- PO Box 230
- Brighton BN2 9TX
- England, United Kingdom
+44 01273 000000
Balmonds Financials Summary
In Thousands, USD |
TTM 31-Mar-2017 | FY 2017 31-Mar-2017 | FY 2016 31-Mar-2016 | FY 2015 31-Mar-2015 |
---|---|---|---|---|
Total Assets | 375 | 375 | 284 | 278 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Balmonds Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Balmonds Executive Team (5)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Weze McIntosh | Managing Director | ||
Natalie Balmond | Co-Owner & Director | ||
Andrew Gerrie | Co-Owner & Co-Founder | ||
Alison Hawksley | Co-Owner |
Balmonds Signals
Balmonds Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000000 00 | 23-May-2022 | 0000000000 | Special Purpose Acquisition Company (SPAC) |